Diabetes mellitus
Conditions
Interventions
Registration of daily life by continu glucose monitoring with a Freestyle Libre Pro sensor (Abbott) and exercise, nutrition, medication and mental status by Gamebus app and smartwatch
Sponsors
Prof dr H. Haak
Eligibility
Inclusion criteria
Inclusion criteria: • Informed consent obtained before trial related activities • 20 patients with type 1 diabetes mellitus and BMI < 30 • 200 patients with type 2 diabetes mellitus • Age above 18 years • Patient’s language skills are sufficient for participation • Subject has a smartphone and is willing to install the needed apps on it.
Exclusion criteria
Exclusion criteria: • Pregnancy of breastfeeding women • Scheduled scan or MRI at time of wearing freestyle libre pro sensor • Malignancy excepted basal and squamous cell skin cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To collect patient gathered health data (PGHD) that is needed for the development of SugarVita. This includes glucose levels from patients with diabetes and information regarding different factors (physical activity, nutrition, medication and mental state) that can influence those levels. Also the HbA1c, C peptide and HOMA-IR index will be used as a clinical measure of glycemic control and insulin resistance and will be used as an outcome measure to determine the effect of playing SugarVita. | — |
Contacts
Public ContactPleun Wouters- van Poppel
Maxima Medical Center
Outcome results
None listed